Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hayden

Showing results (821-830 of 910) with videos related to

Pageof 91
Sort By:
Neurobiology of Disease|August 11, 2006
Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer's disease mouse models with abundant A beta in plasmaBraydon L Burgess, Sean A McIsaac, Kathryn E Naus, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 20, 2008
Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosisMarcia L E MacDonald, Miranda van Eck, Reeni B Hildebrand, et al.
Human Molecular Genetics|August 8, 2002
Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's diseaseEdmond Y W Chan, Ruth Luthi-Carter, Andrew Strand, et al.
Human Molecular Genetics|October 24, 2002
HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosisRoshni R Singaraja, Shinji Hadano, Martina Metzler, et al.
Endocrinology|November 13, 2012
Obesity-related alterations in cardiac lipid profile and nondipping blood pressure pattern during transition to diastolic dysfunction in male db/db miceVincent G Demarco, David A Ford, Erik J Henriksen, et al.
American Journal of Human Genetics|November 12, 2019
A Comprehensive Haplotype-Targeting Strategy for Allele-Specific HTT Suppression in Huntington DiseaseChris Kay, Jennifer A Collins, Nicholas S Caron, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2016
Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptorJoel Kaye, Victor Piryatinsky, Tal Birnberg, et al.
Annals of the New York Academy of Sciences|November 24, 2017
Compositional differences between Copaxone and Glatopa are reflected in altered immunomodulation ex vivo in a mouse modelIris Grossman, Sarah Kolitz, Arthur Komlosh, et al.
BMC Genomics|May 24, 2007
CAG-encoded polyglutamine length polymorphism in the human genomeStefanie L Butland, Rebecca S Devon, Yong Huang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 19, 2015
A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkersAaron Sturrock, Corree Laule, Katy Wyper, et al.
Pageof 91

Showing results (821-830 of 910) with videos related to

Sort By:
Pageof 91
Neurobiology of Disease|August 11, 2006
Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer's disease mouse models with abundant A beta in plasmaBraydon L Burgess, Sean A McIsaac, Kathryn E Naus, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 20, 2008
Despite antiatherogenic metabolic characteristics, SCD1-deficient mice have increased inflammation and atherosclerosisMarcia L E MacDonald, Miranda van Eck, Reeni B Hildebrand, et al.
Human Molecular Genetics|August 8, 2002
Increased huntingtin protein length reduces the number of polyglutamine-induced gene expression changes in mouse models of Huntington's diseaseEdmond Y W Chan, Ruth Luthi-Carter, Andrew Strand, et al.
Human Molecular Genetics|October 24, 2002
HIP14, a novel ankyrin domain-containing protein, links huntingtin to intracellular trafficking and endocytosisRoshni R Singaraja, Shinji Hadano, Martina Metzler, et al.
Endocrinology|November 13, 2012
Obesity-related alterations in cardiac lipid profile and nondipping blood pressure pattern during transition to diastolic dysfunction in male db/db miceVincent G Demarco, David A Ford, Erik J Henriksen, et al.
American Journal of Human Genetics|November 12, 2019
A Comprehensive Haplotype-Targeting Strategy for Allele-Specific HTT Suppression in Huntington DiseaseChris Kay, Jennifer A Collins, Nicholas S Caron, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2016
Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptorJoel Kaye, Victor Piryatinsky, Tal Birnberg, et al.
Annals of the New York Academy of Sciences|November 24, 2017
Compositional differences between Copaxone and Glatopa are reflected in altered immunomodulation ex vivo in a mouse modelIris Grossman, Sarah Kolitz, Arthur Komlosh, et al.
BMC Genomics|May 24, 2007
CAG-encoded polyglutamine length polymorphism in the human genomeStefanie L Butland, Rebecca S Devon, Yong Huang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 19, 2015
A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkersAaron Sturrock, Corree Laule, Katy Wyper, et al.
Pageof 91